Joincare Pharmaceutical Group Industry Co Ltd (600380) — Cash Flow Quality Index
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Cash Flow Quality Index of 3.56x as of September 2025. Operating cash flow of CN¥1.09 Billion exceeds net income of CN¥306.27 Million, indicating high earnings quality where cash backs reported profits. Explore investment intensity of Joincare Pharmaceutical Group Industry C to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Joincare Pharmaceutical Group Industry Co Ltd Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Joincare Pharmaceutical Group Industry C tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year earnings quality comparison for Joincare Pharmaceutical Group Industry Co Ltd. For live market cap and the full company financial profile, see Joincare Pharmaceutical Group Industry C (600380) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.91x | CN¥3.89 Billion | CN¥1.34 Billion | ▲ +139.0% |
| 2024 | 1.22x | CN¥3.64 Billion | CN¥2.98 Billion | ▼ -55.2% |
| 2023 | 2.72x | CN¥3.93 Billion | CN¥1.44 Billion | ▲ +98.1% |
| 2022 | 1.37x | CN¥3.98 Billion | CN¥2.89 Billion | ▲ +40.1% |
| 2021 | 0.98x | CN¥2.56 Billion | CN¥2.61 Billion | ▼ -16.4% |
| 2020 | 1.17x | CN¥3.02 Billion | CN¥2.58 Billion | ▼ -6.1% |
| 2019 | 1.25x | CN¥2.31 Billion | CN¥1.85 Billion | ▼ -0.1% |
| 2018 | 1.25x | CN¥1.83 Billion | CN¥1.46 Billion | ▲ +212.5% |
| 2017 | 0.40x | CN¥1.87 Billion | CN¥4.67 Billion | ▼ -76.3% |
| 2016 | 1.69x | CN¥1.64 Billion | CN¥974.41 Million | ▲ +9.7% |
| 2015 | 1.54x | CN¥1.26 Billion | CN¥821.79 Million | ▲ +7.4% |
| 2014 | 1.43x | CN¥979.46 Million | CN¥683.80 Million | ▲ +28.8% |
| 2013 | 1.11x | CN¥635.52 Million | CN¥571.49 Million | ▼ -33.1% |
| 2012 | 1.66x | CN¥734.36 Million | CN¥441.81 Million | ▲ +25.5% |
| 2011 | 1.32x | CN¥650.36 Million | CN¥491.04 Million | ▲ +20.3% |
| 2010 | 1.10x | CN¥1.11 Billion | CN¥1.00 Billion | ▲ +42.7% |
| 2009 | 0.77x | CN¥605.66 Million | CN¥784.54 Million | ▼ -95.8% |
| 2008 | 18.21x | CN¥455.01 Million | CN¥24.99 Million | ▲ +4254.9% |
| 2007 | 0.42x | CN¥429.26 Million | CN¥1.03 Billion | ▼ -95.5% |
| 2006 | 9.19x | CN¥272.50 Million | CN¥29.64 Million | ▲ +435.3% |
| 2005 | 1.72x | CN¥363.13 Million | CN¥211.45 Million | ▲ +41.4% |
| 2004 | 1.21x | CN¥241.71 Million | CN¥199.06 Million | ▲ +31.2% |
| 2003 | 0.93x | CN¥172.25 Million | CN¥186.14 Million | ▼ -32.7% |
| 2002 | 1.38x | CN¥236.13 Million | CN¥171.63 Million | ▲ +23.3% |
| 2001 | 1.12x | CN¥223.79 Million | CN¥200.62 Million | ▲ +7.1% |
| 2000 | 1.04x | CN¥171.61 Million | CN¥164.79 Million | ▼ -45.8% |
| 1999 | 1.92x | CN¥109.82 Million | CN¥57.20 Million | — |